Rahsaan Thompson - Oct 10, 2022 Form 4 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Role
Chief Legal Officer
Signature
/s/ Hector Casab, as Attorney-in-Fact
Stock symbol
LYEL
Transactions as of
Oct 10, 2022
Transactions value $
$0
Form type
4
Date filed
10/12/2022, 04:10 PM
Previous filing
Oct 3, 2022
Next filing
Feb 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LYEL Option (right to buy) Award $0 +715K $0.00 715K Oct 10, 2022 Common Stock 715K $6.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the option shares shall vest on September 28, 2023, with the remaining option shares to vest in equal monthly installments over the following thirty-six months.